This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This DIRC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 202-229 amino acids from the Central region of human DIRC2.
DIRC2
Reaktivität: Human, Ratte
WB, IF (cc), IF (p)
Wirt: Kaninchen
Polyclonal
AbBy Fluor® 750
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
MGC80843 antikoerper, zgc:92095 antikoerper, rcc4 antikoerper, MGC69320 antikoerper, RCC4 antikoerper, disrupted in renal carcinoma 2 antikoerper, disrupted in renal carcinoma 2 L homeolog antikoerper, disrupted in renal carcinoma 2 (human) antikoerper, DIRC2 antikoerper, dirc2.L antikoerper, dirc2 antikoerper, Dirc2 antikoerper
Hintergrund
This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.